Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 8 Antimicrobial susceptibility (percentage) of Gram-positive bacteria causing bloodstream infection

From: Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study

Drug S. aureus E. faecium* E. faecalis*
  CA 13 HA 17 CA 12 HA 9 CA 9 HA 6
Penicillin 0 0 10 0 17 75
Ampicillin* - - 25 11 100 100
Amoxicillin-clavulanate 77 50 70 11† 100 100
Cloxacillin 92 88 - - - -
Cefuroxime 92 88 - - - -
Ceftazidime 85 80 - - - -
Meropenem 100 100 - - - -
Gentamicin* 100 81 67 33 56 67
Vancomycin* 100 100 100 100 100 100
Erythromycin 100 71 0 0 22 33
Doxycycline 62 35 9 0 25 0
Co-trimoxazole 69 63 27 0 67 40
Chloramphenicol 85 73 50 11 38 33
Ciprofloxacin* 77 81 42 22 100 100
Linezolid* - - 100 100 100 100
Quinupristin-dalfopristin* - - 100 100 0 17
  1. CA, community-acquired infection; HA, hospital-acquired infection; "-", not done. *E-test was used for susceptibility testing of enterococci against ampicillin, ciprofloxacillin, linezolid, quinupristin-dalfopristin, vancomycin and high-level gentamicin resistance. † Statistically significant difference in susceptibility among hospital-acquired and community-acquired isolates, p < 0.05 by two-sided Fisher's exact test.
Back to article page